Brookfield Asset Management Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Brookfield Asset Management Inc.

  • $14.2 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 16, 2022
BUY
$27.79 - $50.61 $2.28 Million - $4.15 Million
82,048 New
82,048 $2.89 Million
Q2 2022

Aug 15, 2022
BUY
$27.79 - $50.61 $2.04 Million - $3.71 Million
73,393 Added 847.98%
82,048 $2.89 Million
Q2 2021

Aug 17, 2021
BUY
$62.15 - $90.32 $537,908 - $781,719
8,655 New
8,655 $716,000

Others Institutions Holding ARWR

# of Institutions
305
Shares Held
95.9M
Call Options Held
523K
Put Options Held
493K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email